press releases

Novadip Biosciences Raises Additional EUR 40 Million Bringing Total Company Funding to EUR 88 Million

November 4, 2022


We are excited to announce the Novadip team raised EUR 40 million in a #SeriesB funding round!

This funding will help us accelerate the clinical development of our two investigational adipose stem cell-derived tissue regeneration products: NVD-X3 and NVD-003.

We are appreciative of our team of investors for their support to provide accelerated healing for patients with large bone defects and injuries in a single treatment. View our company announcement:

#Novadip #regenerativemedicine #clinicalresearch #boneregeneration #tissueengineering